Ключевые слова:
Bachadon bo‘yni displaziyasi; bachadon bo‘yni saratoni; sitomorfologiya; immunogistokimyo; Ki-67; PD-L1; proliferativ faollik; immun qochish mexanizmi; o‘sma oldi holat; prognostik markerlarБиблиографические ссылки
Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.
Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999;340(2):115–126.
Goldstein J.L., Brown M.S. A century of cholesterol and coronaries. Cell. 2015;161(1):161–172.
Dietschy J.M., Turley S.D. Cholesterol metabolism in the brain. J Lipid Res. 2004;45(8):1375–1397.
Puglielli L., Tanzi R.E., Kovacs D.M. Alzheimer’s disease: the cholesterol connection. Nat Neurosci. 2003;6(4):345–351.
Björkhem I., Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol. 2004;24(5):806–815.
Sparks D.L. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer’s disease? Ann N Y Acad Sci. 1997;826:128–146.
de la Torre J.C. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer’s disease. J Alzheimers Dis. 2012;32(3):553–567.
Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–866.
Grammas P. Neurovascular dysfunction, inflammation and endothelial activation. J Neuroinflammation. 2011;8:26.
Calderón-Garcidueñas L., et al. Nicotine effects on the brain and glial activation. Toxicol Pathol. 2013;41(2):346–358.
Durazzo T.C., Meyerhoff D.J. Neurobiological and neurocognitive effects of chronic cigarette smoking. J Neurochem. 2007;102(4):1143–1159.
Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 2009;44(2): 136–140.
Crews F.T., Nixon K. Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol. 2009;44(2):115–127.
Mattson M.P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1(2):120–129.
Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119( 1):7–35.
Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50(4):427–434.
Zlokovic B.V. Neurovascular pathways to neurodegeneration. Nat Rev Neurosci. 2011;12(12): 723–738.
Brown R.C., Davis T.P. Hypoxia/aglycemia alters blood–brain barrier function. J Cereb Blood Flow Metab. 2002;22(8):947–954.
Barone E., Butterfield D.A. Lipid peroxidation and oxidative stress in neurodegeneration. Free Radic Biol Med. 2015;82:93–100.
Reitz C. Dyslipidemia and dementia: current epidemiology. Curr Opin Lipidol. 2013;24(3): 205–210.
Anstey K.J., et al. Smoking as a risk factor for dementia. Am J Epidemiol. 2007;166(4):367–378.
Topiwala A., et al. Moderate alcohol consumption and brain structure. BMJ. 2017;357:j2353.
Ridker P.M. Inflammatory biomarkers and vascular disease. Circulation. 2001;103(13):1813–1818.
World Health Organization. Global status report on noncommunicable diseases. Geneva: WHO; 2022.